about
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell deathVorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma.Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat.Immunopathogenesis and therapy of cutaneous T cell lymphoma.The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indicationsVorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma.Outsmarting cutaneous T-cell lymphoma cells by decoding the language they speak: focusing past and present insights on future prospectsThymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosisMycosis fungoides: case report and literature review.Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.Targeting histone deacetyalses in the treatment of B- and T-cell malignancies.Treatment of mycosis fungoides: overview.Identification of p38β as a therapeutic target for the treatment of Sézary syndrome.Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)TOX acts an oncological role in mycosis fungoides.Implications of bax, fas, and p53 in the pathogenesis of early-stage mycosis fungoides and alterations in expression following photochemotherapy.Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.Cancer in Jews: introduction and overview.Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.Serum Vitamin D and Vitamin D Receptor Gene Polymorphism in Mycosis Fungoides Patients: A Case Control Study.Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphomaApoptosis Induction and Gene Expression Profile Alterations of Cutaneous T-Cell Lymphoma Cells following Their Exposure to Bortezomib and MethotrexateAge, race, sex, stage, and incidence of cutaneous lymphomaCCR4 as a novel molecular target for immunotherapy of cancer.Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphomaThe diagnosis, staging, and treatment options for mycosis fungoides.Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genesInterleukin-16 as a marker of Sézary syndrome onset and stage.Menus for managing patients with cutaneous T-cell lymphoma.Molecular cytogenetics in the study of cutaneous T-cell lymphomas (CTCL).TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma.Treatment of transformed mycosis fungoides with intermittent low-dose gemcitabine.Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma.Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.Investigating heredity in cutaneous T-cell lymphoma in a unique cohort of Danish twins.Phototherapy of mycosis fungoides.Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome.Management of cutaneous T cell lymphoma: new and emerging targets and treatment options.Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art.
P2860
Q24629558-C2962F0D-958B-4FE0-9605-26A6B9BBC19DQ24685820-F1C18FAC-8EC6-4BF0-B6F2-BADFB14D6E4FQ33375694-4B8E45E6-2862-4D26-9D2F-97840BD55377Q33385966-E6C13BF0-3C53-4EA4-B28C-4ABC78B5BC1CQ33726963-BEC82F25-30DF-430D-BCE6-B0186878BC85Q33746059-BDC98B9D-4708-4784-AB94-8F2EC7737F3BQ33800456-8F277BA8-670A-4149-B232-1F87A3B5FAB9Q33821398-D4A84AB3-C51F-4D23-8BA4-D0251634EF25Q34100988-91D77DB7-3656-4A16-87E9-9F7A674FFE4BQ34156362-381E6384-1EA4-4F0B-9F25-D7B7C209A4CDQ34413695-DDF0E339-94EC-46DA-BA68-AADFBF61D708Q34414452-10D53891-532C-4A4F-89B1-F44EB7ED32EFQ34574172-520EB98E-E118-4D07-B699-13D8A0ACAE20Q34899213-E7FFB5DE-151B-4151-81DF-6DBA4135B13BQ35022833-DD948D8C-D50B-45E7-9F7B-DA199B94294AQ35219716-85F3A62A-F3FF-4823-93ED-558C04B87B26Q35564608-EF321DA4-9A91-4029-B097-8FADB7093938Q35584244-B2810727-B8B0-4FC0-A887-2AEE511CA4D0Q35934020-76340ABA-D037-4957-A5DC-EF7A79BEEBB6Q36020985-8F512427-6E27-4027-876A-EC7CC48E9B9CQ36059716-F615DEAA-4D18-42CF-A325-DCD09D3EEDC9Q36070459-C6FB5848-83A5-4D4F-A7A5-932C2338222BQ36255777-962A7F65-6936-4B41-96DF-721DF43576C0Q36330634-1446908B-75AB-4A49-B844-2DD04ECA20D7Q36585299-E3D4D8F2-B324-435D-B399-4FB06B54712BQ36675064-A2F589E1-ED04-411F-847A-8E93FF2777BAQ36771218-C9CE81C8-D365-4BA3-90C8-C58580C5C33BQ36793430-C315CC6D-1FBB-4C43-8A67-36CE35229A40Q36890797-9CF7FF77-CE6F-4E33-A953-660A84B3C29AQ36934406-7CDD468A-CB4E-4A03-91C4-D29F741059D5Q37000311-96F0A6E4-2891-4C61-BE1A-3CBEF16921CCQ37025122-346B8E4E-6B26-4E83-849B-1EBF5E18ACA4Q37109167-C2D9EA4A-44D9-4428-A294-F22C091C6E09Q37139517-90E028E8-F12D-4C9D-AEE4-938BBD9BEA0EQ37237464-2CE28851-1D16-4017-8463-A2078155A8ADQ37634755-3E701E79-898E-4FBC-B015-E2133677BD4EQ37851562-295586F4-78F2-4177-A03C-C2FB0EB12527Q37929548-EEBFBEE4-1E88-4947-AB6D-BD12440A2F2EQ37998019-3EA5D85F-6574-4213-A5C0-F82A7571F651Q38010239-87B176AC-13FB-49A6-ABC9-3263E27ADAD6
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The pathogenesis of mycosis fungoides.
@ast
The pathogenesis of mycosis fungoides.
@en
The pathogenesis of mycosis fungoides.
@nl
type
label
The pathogenesis of mycosis fungoides.
@ast
The pathogenesis of mycosis fungoides.
@en
The pathogenesis of mycosis fungoides.
@nl
prefLabel
The pathogenesis of mycosis fungoides.
@ast
The pathogenesis of mycosis fungoides.
@en
The pathogenesis of mycosis fungoides.
@nl
P2093
P356
P1476
The pathogenesis of mycosis fungoides.
@en
P2093
Lynn D Wilson
Michael Girardi
Peter W Heald
P304
P356
10.1056/NEJMRA032810
P407
P577
2004-05-01T00:00:00Z